IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activityMinkyung Song, Juan R. Cubillos‐Ruiz, Andrew V. Kossenkov et al.|Nature|2018Cited by 408
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapyDmitriy Zamarin, Jedd D. Wolchok|Journal of Clinical Investigation|2018Cited by 148
Ovarian cancer-derived IL-4 promotes immunotherapy resistanceGürkan Mollaoglu, Brian D. Brown, Alexander Tepper et al.|Cell|2024Cited by 99
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analysesClaire F. Friedman, Dmitriy Zamarin|Nature Medicine|2024Cited by 25
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Dmitriy Zamarin|Science Advances|2024Cited by 9